Literature DB >> 33472229

Platypnea-Orthodeoxia Syndrome Caused by an Intracardiac Shunt.

Sanket P Borgaonkar1, Wilson W Lam1,2, Mehdi Razavi1,3, Dhaval R Parekh1.   

Abstract

Platypnea-orthodeoxia syndrome, a rare condition characterized by posture-related dyspnea, is usually caused by an intracardiac shunt, hepatopulmonary syndrome, or shunting resulting from severe pulmonary disease. We report the case of a 33-year-old woman who presented with increasing dyspnea and oxygen desaturation when she sat up or arose. Our diagnosis was platypnea-orthodeoxia syndrome. A lead of a previously implanted pacemaker exacerbated a severe tricuspid regurgitant jet that was directed toward the patient's intra-atrial septum. Percutaneous closure of a small secundum atrial septal defect eliminated right-to-left shunting and substantially improved the patient's functional status. In addition to this case, we discuss this unusual condition.
© 2020 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Defibrillators, implantable/adverse effects; dyspnea/etiology; heart septal defects, atrial/complications/diagnostic imaging/therapy; hypoxia/etiology; posture/physiology; treatment outcome; tricuspid valve insufficiency/complications

Year:  2020        PMID: 33472229      PMCID: PMC7819445          DOI: 10.14503/THIJ-16-6094

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  11 in total

1.  Platypnea-orthodeoxia syndrome occurring after a blunt chest trauma with acute tricuspid regurgitation.

Authors:  Pai-Feng Hsu; Hsing-Bang Leu; Tse-Min Lu; Wen-Chung Yu; Tsui-Lieh Hsu
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

2.  Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry.

Authors:  P Guérin; V Lambert; F Godart; A Legendre; J Petit; F Bourlon; B De Geeter; A Petit; B Monrozier; A M Rossignol; M Jimenez; D Crochet; A Choussat; C Rey; J Losay
Journal:  Cardiovasc Intervent Radiol       Date:  2005 Mar-Apr       Impact factor: 2.740

3.  PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).

Authors:  Paul Khairy; George F Van Hare; Seshadri Balaji; Charles I Berul; Frank Cecchin; Mitchell I Cohen; Curt J Daniels; Barbara J Deal; Joseph A Dearani; Natasja de Groot; Anne M Dubin; Louise Harris; Jan Janousek; Ronald J Kanter; Peter P Karpawich; James C Perry; Stephen P Seslar; Maully J Shah; Michael J Silka; John K Triedman; Edward P Walsh; Carole A Warnes
Journal:  Can J Cardiol       Date:  2014-10       Impact factor: 5.223

4.  Platypnoea-orthodeoxia syndrome.

Authors:  P Kubler; H Gibbs; P Garrahy
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 5.  Cardiac platypnea-orthodeoxia syndrome: an often unrecognized malady.

Authors:  Joseph T Knapper; Jason Schultz; Gladwin Das; Laurence S Sperling
Journal:  Clin Cardiol       Date:  2014-06-09       Impact factor: 2.882

6.  Persistent Eustachian valve causing severe cyanosis in atrial septal defect with normal right heart pressures.

Authors:  T Bashour; S Kabbani; M Saalouke; T O Cheng
Journal:  Angiology       Date:  1983-02       Impact factor: 3.619

7.  Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients.

Authors:  Eustaquio Onorato; Gloria Melzi; Francesco Casilli; Luigi Pedon; Gianluca Rigatelli; Antonio Carrozza; Pietro Maiolino; Mario Zanchetta; Eva Morandi; Silvia Angeli; Gian Paolo Anzola
Journal:  J Interv Cardiol       Date:  2003-02       Impact factor: 2.279

8.  Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study.

Authors:  Paul Khairy; Michael J Landzberg; Michael A Gatzoulis; Lise-Andrée Mercier; Susan M Fernandes; Jean-Marc Côté; Jean-Pierre Lavoie; Anne Fournier; Peter G Guerra; Alexandra Frogoudaki; Edward P Walsh; Annie Dore
Journal:  Circulation       Date:  2006-05-15       Impact factor: 29.690

9.  Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.

Authors:  Evan P Kransdorf; Lisa N Kransdorf; F David Fortuin; John P Sweeney; Susan Wilansky
Journal:  Tex Heart Inst J       Date:  2016-04-01

10.  ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2008-12-02       Impact factor: 24.094

View more
  1 in total

1.  Platypnea-orthodeoxia Syndrome Due to Right Ventricular Inflow Tract Obstruction Caused by an Elongated Ascending Aorta: Usefulness of Three-dimensional Cardiac Computed Tomography Imaging in the Sitting Position.

Authors:  Yuki Hasegawa; Daisuke Izumi; Yasuhiro Ikami; Takeshi Okubo; Makoto Hoyano; Kazuyuki Ozaki; Noriaki Sato; Takehito Mishima; Takayuki Inomata
Journal:  Intern Med       Date:  2022-01-13       Impact factor: 1.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.